ABCL Competitors & Alternatives
Compare Abcellera Biologics Inc with similar stocks in the same industry
Biotechnology
ABCL
Main Stock$5.74
Tradestie Score
56
Market Cap
$1.78B
Revenue Growth
1.0%
Analyst Upside
+81.7%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.35
|
$1.81B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.87
|
$1.78B | - | 60 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.63
|
$1.74B | - | 65 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$33.41
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$3.89
|
$1.65B | - | 65 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$36.50
|
$1.63B | - | 64 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.50
|
$1.57B | - | 61 | Compare |
|
SDGR
Schrodinger, Inc. Common Stock
|
$15.23
|
$1.56B | - | 56 | Compare |
|
VCEL
Vericel Corporation
|
$40.47
|
$1.56B | 93.3 | 56 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$87.37
|
$1.55B | - | 57 | Compare |
More ABCL Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry